1118 related articles for article (PubMed ID: 19451858)
21. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
[TBL] [Abstract][Full Text] [Related]
22. Outcome of HIV infected children with culture confirmed tuberculosis.
Hesseling AC; Westra AE; Werschkull H; Donald PR; Beyers N; Hussey GD; El-Sadr W; Schaaf HS
Arch Dis Child; 2005 Nov; 90(11):1171-4. PubMed ID: 15964862
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
24. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
25. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
[TBL] [Abstract][Full Text] [Related]
26. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya.
Braitstein P; Katshcke A; Shen C; Sang E; Nyandiko W; Ochieng VO; Vreeman R; Yiannoutsos CT; Wools-Kaloustian K; Ayaya S
Trop Med Int Health; 2010 Jul; 15(7):833-41. PubMed ID: 20487430
[TBL] [Abstract][Full Text] [Related]
27. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
28. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
29. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
30. The epidemiology of HIV-associated tuberculosis in rural Cambodia.
Cain KP; Kanara N; Laserson KF; Vannarith C; Sameourn K; Samnang K; Qualls ML; Wells CD; Varma JK
Int J Tuberc Lung Dis; 2007 Sep; 11(9):1008-13. PubMed ID: 17705980
[TBL] [Abstract][Full Text] [Related]
31. Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data.
Coovadia HM; Jeena P; Wilkinson D
Int J Tuberc Lung Dis; 1998 Oct; 2(10):844-51. PubMed ID: 9783533
[TBL] [Abstract][Full Text] [Related]
32. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
33. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children.
Zampoli M; Kilborn T; Eley B
Int J Tuberc Lung Dis; 2007 Apr; 11(4):417-23. PubMed ID: 17394688
[TBL] [Abstract][Full Text] [Related]
35. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
[TBL] [Abstract][Full Text] [Related]
36. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
Dowdy DW; Chaisson RE; Moulton LH; Dorman SE
AIDS; 2006 Mar; 20(5):751-62. PubMed ID: 16514306
[TBL] [Abstract][Full Text] [Related]
37. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa.
Jeena PM; Pillay P; Pillay T; Coovadia HM
Int J Tuberc Lung Dis; 2002 Aug; 6(8):672-8. PubMed ID: 12150478
[TBL] [Abstract][Full Text] [Related]
38. Pediatric tuberculosis: global overview and challenges.
Swaminathan S; Rekha B
Clin Infect Dis; 2010 May; 50 Suppl 3():S184-94. PubMed ID: 20397947
[TBL] [Abstract][Full Text] [Related]
39. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.
Rajasekaran S; Jeyaseelan L; Vijila S; Gomathi C; Raja K
AIDS; 2007 Jul; 21 Suppl 4():S47-53. PubMed ID: 17620752
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
Kwange SO; Budambula NL
Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
